
Region:Middle East
Author(s):Yogita Sahu
Product Code:KROD5115
October 2024
88

By Species: The market is segmented by species into companion animals and livestock animals. The livestock segment dominates the market due to the Kingdom's significant reliance on livestock for both food security and economic sustainability. Among livestock, poultry, cattle, and sheep are the most critical, as they form the backbone of the meat and dairy industries. Poultry has seen the largest market share due to its high consumption in local diets and substantial production growth driven by government subsidies and disease control measures.

By Product Type: The market in Saudi Arabia is segmented by product type into pharmaceuticals, vaccines, diagnostics, and feed additives. The pharmaceuticals segment dominates the market, accounting for the largest market share. This dominance can be attributed to the increasing need for medication to treat prevalent animal diseases and the growth of livestock farming. Veterinary antibiotics, anti-parasitics, and hormonal products are in high demand due to the efforts to increase productivity and manage disease outbreaks in livestock.

The market is highly competitive, with both global and local players influencing the market dynamics. International companies dominate, largely due to their advanced R&D capabilities and strong product portfolios. However, local firms are increasingly gaining traction through partnerships and joint ventures.
|
Company Name |
Establishment Year |
Headquarters |
Veterinary Portfolio |
R&D Investment |
Distribution Network |
Global Presence |
Local Market Strategy |
Product Innovation |
Partnerships |
|
Boehringer Ingelheim |
1885 |
Ingelheim, Germany |
|||||||
|
Zoetis |
1952 |
Parsippany, NJ, USA |
|||||||
|
Merck Animal Health |
1891 |
Rahway, NJ, USA |
|||||||
|
Almarai |
1977 |
Riyadh, Saudi Arabia |
|||||||
|
Elanco Animal Health |
1954 |
Greenfield, IN, USA |
Over the next five years, the Saudi Arabian animal health industry is expected to see substantial growth, driven by increased demand for livestock products, rising pet ownership, and government initiatives to ensure food security. The Kingdoms Vision 2030 emphasizes improving agricultural sustainability and animal welfare, further fueling the demand for veterinary services and products.
|
By Species |
Companion Animals Livestock Animals |
|
By Product Type |
Pharmaceuticals Vaccines Diagnostics Feed Additives |
|
By Distribution Channel |
Veterinary Hospitals Online Pharmacies Retail Pharmacies Distributors |
|
By End-Use Application |
Preventive Care Therapeutic Care Diagnostic Care |
|
By Region |
North East West South |
Government and Regulatory Bodies (Ministry of Environment, Water, and Agriculture)
Banks and Financial Instututions
Private Equity Firms
Animal Pharmaceutical Manufacturers
Veterinary Service Providers
Animal Nutrition Companies
Investors and Venture Capital Firms
1.1 Definition and Scope
1.2 Market Taxonomy
1.3 Market Growth Rate
1.4 Market Segmentation Overview
2.1 Historical Market Size
2.2 Year-On-Year Growth Analysis
2.3 Key Market Developments and Milestones
3.1 Growth Drivers
3.1.1 Expansion of Livestock Farming
3.1.2 Rising Pet Ownership
3.1.3 Increasing Focus on Animal Disease Prevention
3.1.4 Government Support and Initiatives
3.2 Market Challenges
3.2.1 High Cost of Veterinary Care
3.2.2 Lack of Skilled Veterinary Professionals
3.2.3 Strict Regulatory Environment
3.2.4 Disease Control Complexity
3.3 Opportunities
3.3.1 Growing Demand for Advanced Veterinary Pharmaceuticals
3.3.2 Expansion of Veterinary Clinics and Hospitals
3.3.3 Digitalization in Animal Health Services
3.3.4 Partnerships with Global Animal Health Companies
3.4 Trends
3.4.1 Rising Adoption of Animal Health Technology
3.4.2 Growth in Veterinary Pharmaceuticals Market
3.4.3 Focus on Animal Welfare Regulations
3.4.4 Integration of Livestock Management Systems
3.5 Government Regulations
3.5.1 Saudi Vision 2030 Animal Welfare Initiatives
3.5.2 Import and Distribution Regulations for Animal Health Products
3.5.3 Veterinary Drug Approval Processes
3.5.4 Disease Control Programs and Vaccination Policies
3.6 SWOT Analysis
3.7 Stakeholder Ecosystem
3.8 Porters Five Forces Analysis
3.9 Competition Ecosystem
4.1 By Species (In Value %)
4.1.1 Companion Animals (Cats, Dogs, Others)
4.1.2 Livestock Animals (Cattle, Sheep, Poultry, Others)
4.2 By Product Type (In Value %)
4.2.1 Pharmaceuticals
4.2.2 Vaccines
4.2.3 Diagnostics
4.2.4 Feed Additives
4.3 By Distribution Channel (In Value %)
4.3.1 Veterinary Hospitals
4.3.2 Online Pharmacies
4.3.3 Retail Pharmacies
4.3.4 Distributors
4.4 By End-Use Application (In Value %)
4.4.1 Preventive Care
4.4.2 Therapeutic Care
4.4.3 Diagnostic Care
4.5 By Region (In Value %)
4.5.1 North
4.5.2 East
4.5.3 West
4.5.4 South
5.1 Detailed Profiles of Major Companies
5.1.1 Boehringer Ingelheim
5.1.2 Merck Animal Health
5.1.3 Zoetis Inc.
5.1.4 Ceva Sant Animale
5.1.5 Vetoquinol
5.1.6 Elanco Animal Health
5.1.7 IDEXX Laboratories
5.1.8 Bayer Animal Health
5.1.9 Nutreco
5.1.10 Biogenesis Bago
5.1.11 Virbac
5.1.12 Neogen Corporation
5.1.13 Kemin Industries
5.1.14 Almarai
5.1.15 Saudi Pharmaceutical Industries
5.2 Cross Comparison Parameters (Headquarters, Product Portfolio, Revenue, Global Presence, Market Share, No. of Employees, R&D Spending, Animal Health Focus)
5.3 Market Share Analysis (Company-wise and Product-wise)
5.4 Strategic Initiatives (Partnerships, New Product Launches, Collaborations)
5.5 Mergers and Acquisitions
5.6 Investment Analysis (Private Investments, Government Funding)
5.7 Venture Capital Funding
5.8 Government Grants and Incentives
6.1 Compliance Requirements for Veterinary Products
6.2 Import and Export Regulations for Animal Health Products
6.3 Veterinary Certification and Licensing Processes
7.1 Future Market Size Projections
7.2 Key Factors Driving Future Market Growth
8.1 By Species
8.2 By Product Type
8.3 By Distribution Channel
8.4 By End-Use Application
8.5 By Region
9.1 TAM/SAM/SOM Analysis
9.2 Customer Cohort Analysis
9.3 Marketing Initiatives
9.4 White Space Opportunity Analysis
The initial stage involves creating an ecosystem map of stakeholders in the Saudi Arabia Animal Health Market. This includes extensive desk research to identify key players, market dynamics, and significant trends that influence market growth, including livestock farming practices and veterinary care.
In this phase, we collect and analyze historical data on the Saudi Arabia Animal Health Market. Factors such as veterinary product sales, the number of livestock farms, and animal disease outbreaks are assessed to generate reliable market size estimates.
Market hypotheses are developed and validated through interviews with industry experts, including veterinarians, livestock farmers, and representatives from animal pharmaceutical companies. This step ensures accuracy in market data and insights.
The final phase involves synthesizing data from various sources and confirming findings through direct engagement with animal health companies. This ensures the report provides a comprehensive and accurate analysis of the Saudi Arabia Animal Health Market.
The Saudi Arabia animal health market is valued at USD 384 million, driven by growth in livestock farming and rising pet ownership.
Challenges in the Saudi Arabia animal health market include high costs of veterinary care, a shortage of skilled veterinary professionals, and complex disease control issues among livestock.
Key players in the Saudi Arabia animal health market include Boehringer Ingelheim, Zoetis, Merck Animal Health, Ceva Sant Animale, and Vetoquinol, who lead the market with strong product portfolios and distribution networks.
The Saudi Arabia animal health market is driven by the expansion of livestock farming, increasing pet ownership, government disease control initiatives, and advancements in veterinary pharmaceuticals.
Key trends in the Saudi Arabia animal health market include the adoption of animal health technology, increased focus on disease prevention, and the growth of veterinary services in urban regions such as Riyadh and Jeddah.
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.